90 related articles for article (PubMed ID: 2287063)
21. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
22. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
23. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
[TBL] [Abstract][Full Text] [Related]
24. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
[TBL] [Abstract][Full Text] [Related]
25. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF
J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061
[TBL] [Abstract][Full Text] [Related]
27. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
29. The role of vascular endothelial cells in the regulation of fibrinolysis.
Grulich-Henn J; Müller-Berghaus G
Z Kardiol; 1989; 78 Suppl 6():25-9. PubMed ID: 2694664
[TBL] [Abstract][Full Text] [Related]
30. [Progress in the detection of intravascular activation of fibrinolysis].
Zawilska K
Acta Haematol Pol; 1995; 26(1):33-8. PubMed ID: 7747560
[TBL] [Abstract][Full Text] [Related]
31. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
[TBL] [Abstract][Full Text] [Related]
32. Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH).
Mahmoud M; Gaffney PJ
Thromb Haemost; 1985 Jun; 53(3):356-9. PubMed ID: 3931284
[TBL] [Abstract][Full Text] [Related]
33. Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator.
Tran-Thang C; Vouillamoz D; Kruithof EK; Sordat B
J Cell Physiol; 1994 Nov; 161(2):285-92. PubMed ID: 7962113
[TBL] [Abstract][Full Text] [Related]
34. Coagulant and fibrinolytic activities in the leukemic cell lysates.
Wada H; Nagano T; Tomeoku M; Kuto M; Karitani Y; Deguchi K; Shirakawa S
Thromb Res; 1983 May; 30(4):315-22. PubMed ID: 6351339
[TBL] [Abstract][Full Text] [Related]
35. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
[TBL] [Abstract][Full Text] [Related]
36. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
Colucci M; Paramo JA; Collen D
J Clin Invest; 1985 Mar; 75(3):818-24. PubMed ID: 3920245
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of tissue type plasminogen activator by leukaemic cell homogenates.
Wada H; Kumeda Y; Ogasawara Z; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Kageyama S; Kobayashi T
Blood Coagul Fibrinolysis; 1993 Aug; 4(4):591-7. PubMed ID: 8218856
[TBL] [Abstract][Full Text] [Related]
38. Fibrinogenolysis in thrombotic thrombocytopenic purpura.
Kakishita E; Koyama T; Higuchi M; Kunitomi O; Oura Y; Nagai K
Am J Hematol; 1989 Sep; 32(1):14-9. PubMed ID: 2502913
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
Koh SC; Anandakumar C; Montan S; Ratnam SS
Gynecol Obstet Invest; 1993; 35(4):214-21. PubMed ID: 8330765
[TBL] [Abstract][Full Text] [Related]
40. Influence of delivery on plasminogen activator inhibitor activity.
Koelbl H; Kirchheimer J; Tatra G
J Perinat Med; 1989; 17(2):107-11. PubMed ID: 2681664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
